The effect of metformin on cognitive function: A systematic review and meta-analysis.
Cognitive function
dementia
diabetes
metformin
mild cognitive impairment
Journal
Journal of psychopharmacology (Oxford, England)
ISSN: 1461-7285
Titre abrégé: J Psychopharmacol
Pays: United States
ID NLM: 8907828
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
pubmed:
18
3
2022
medline:
3
6
2022
entrez:
17
3
2022
Statut:
ppublish
Résumé
Most people are familiar with metformin as a diabetic treatment option. Different positive benefits have been found for it, in addition to its anti-diabetes properties. Cognitive function enhancement is the most recent characteristic that has been studied. This study aimed to look at the evidence on the effects of metformin on cognitive performance. Web of Science, PubMed, Scopus, the Cochrane Library, EMBASE, and PsycINFO databases were searched systematically. After eliminating duplicates and irrelevant documents, the findings were screened. The documents that remained were scanned and data were extracted. Nineteen studies were qualified for meta-analysis after evaluating 3827 identified records. There was no significant relationship between metformin therapy and cognitive performance in none of the studies including cross-sectionals, cohorts, and clinical trials (
Identifiants
pubmed: 35297284
doi: 10.1177/02698811211057304
doi:
Substances chimiques
Metformin
9100L32L2N
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM